Clinical trials play a crucial role in shaping the practice of medicine. Nonreporting of clinical trial results affects the validity of the literature and can negatively affect patient care. Lung cancer is the leading cause of cancer-related mortality in the United States and worldwide.
1 Studies assessing reporting of clinical trial results in thoracic oncology are lacking. We sought to investigate the publication rate among registered lung cancer clinical trials.